Health Care

The North Central Massachusetts Development Corp. loaned $100,000 to DivineTouch Home Health Care in Worcester to support the agency in becoming a certified homecare agency by the Massachusetts Division of Health Care Facility Licensure and Certification.

A new bill aims to broaden access to a medical advancement that allows for more targeted and precise cancer treatment, but the legislation could encounter opposition from the insurance industry, which opposes coverage mandates.

The Healey Administration warned pharmacies across Massachusetts on Wednesday: keep reproductive health medications, including a drug approved to end a pregnancy in early stages, in stock or face state investigation.

UMass Chan Medical School in Worcester has received official approval from the Liaison Committee on Medical Education to establish its new regional campus in Burlington in partnership with Lahey Hospital & Medical Center.

Two Central Massachusetts nonprofits and their partner hospitals will receive 20% of the $3 million in grants awarded by the Gov. Maura Healey Administration to aging services access points across Massachusetts.

In a partnership with the Worcester nonprofit Central Massachusetts Agency on Aging, the Quinsigamond Community College dental clinic piloted offering free dental services to seniors after offering care at a low cost for two decades.

The Edward M. Kennedy Community Health Center’s new 605 Lincoln Street facility is slated to open to patients the first week of April, aiming to expand health equity in Worcester.

Marlborough firm Akoya Biosciences named Johnny Ek to replace Joe Driscoll as the firm’s CFO, becoming the second new member of the company’s C-suite this year, after Jennifer Kamocsay was picked as general counsel.

Gov. Maura Healey has now proposed over $56.5 billion in state spending since taking office, adding a $734 million supplemental budget request to her agenda on Friday.

A new group of patient advocates, business leaders and independent pharmacists will wade into debate this term over the role of pharmacy benefit managers at a time when prescription drug prices are on the rise.